QT
ACAD icon

Quantamental Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History

Quantamental Technologies’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,669
Closed -$279K – 292
2023
Q2 		$279K Buy
+11,669
New +$259K 0.12% 302
2020
Q4 		– Sell
-12,033
Closed -$496K – 97
2020
Q3 		$496K Buy
+12,033
New +$520K 0.37% 81
2019
Q3 		– Sell
-2,130
Closed -$57K – 1490
2019
Q2 		$57K Buy
+2,130
New +$54.4K 0.02% 853

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Quantamental Technologies's ACAD Position: Q3 2023 in Review

Quantamental Technologies sold out of Acadia Pharmaceuticals (ACAD) in Q3 2023, closing a stake of 11,669 shares — an estimated $279K sold.

Quantamental Technologies first reported a position in ACAD in Q2 2019 and held it in 3 quarters. The position peaked at $496K in Q3 2020. 248 funds tracked by Wall St. Rank hold ACAD as of Q3 2023.

  • Quantamental Technologies reported no remaining Acadia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 11,669 Acadia Pharmaceuticals shares in Q3 2023, an estimated $279K.
  • Quantamental Technologies first reported a position in Acadia Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Quantamental Technologies's Acadia Pharmaceuticals position peaked at $496K in Q3 2020.
  • 248 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.